Bio-Techne (TECH) Cash from Operations Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 158.60% |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 110.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 110.75% |
| Dec 31, 2025 | -2.29% |
| Sep 30, 2025 | -56.82% |
| Jun 30, 2025 | 30.07% |
| Mar 31, 2025 | -49.23% |
| Dec 31, 2024 | 1.48% |
| Sep 30, 2024 | 7.59% |
| Jun 30, 2024 | -9.47% |
| Mar 31, 2024 | 60.26% |
| Dec 31, 2023 | 29.09% |
| Sep 30, 2023 | 5.89% |
| Jun 30, 2023 | -18.81% |
| Mar 31, 2023 | -30.90% |
| Dec 31, 2022 | -36.25% |
| Sep 30, 2022 | 15.79% |
| Jun 30, 2022 | -15.82% |
| Mar 31, 2022 | -2.32% |
| Dec 31, 2021 | 13.13% |
| Sep 30, 2021 | -26.63% |
| Jun 30, 2021 | 172.42% |
| Mar 31, 2021 | 51.34% |
| Dec 31, 2020 | 26.77% |
| Sep 30, 2020 | 62.83% |
| Jun 30, 2020 | -19.94% |
| Mar 31, 2020 | 24.73% |
| Dec 31, 2019 | 51.23% |
| Sep 30, 2019 | 2.77% |
| Jun 30, 2019 | -13.72% |
| Mar 31, 2019 | 83.20% |
| Dec 31, 2018 | 18.84% |
| Sep 30, 2018 | -11.74% |
| Jun 30, 2018 | 27.52% |
| Mar 31, 2018 | -13.47% |
| Dec 31, 2017 | -5.88% |
| Sep 30, 2017 | 68.65% |
| Jun 30, 2017 | 38.75% |
| Mar 31, 2017 | -32.63% |
| Dec 31, 2016 | 8.02% |
| Sep 30, 2016 | -16.75% |
| Jun 30, 2016 | -1.32% |
| Mar 31, 2016 | 20.67% |
| Dec 31, 2015 | 7.87% |
| Sep 30, 2015 | -10.88% |
| Jun 30, 2015 | -2.06% |
| Mar 31, 2015 | -11.90% |
| Dec 31, 2014 | 14.06% |
| Sep 30, 2014 | 9.61% |
| Jun 30, 2014 | 26.46% |
| Mar 31, 2014 | 5.78% |
| Dec 31, 2013 | 0.11% |
| Sep 30, 2013 | 11.35% |
| Jun 30, 2013 | -19.85% |
| Mar 31, 2013 | -4.17% |
| Dec 31, 2012 | 53.08% |
| Sep 30, 2012 | -15.01% |
| Jun 30, 2012 | 7.91% |
| Mar 31, 2012 | 6.41% |
| Dec 31, 2011 | -30.56% |
| Sep 30, 2011 | 12.15% |
| Jun 30, 2011 | 9.10% |
| Mar 31, 2011 | 39.49% |
| Dec 31, 2010 | 4.25% |
| Sep 30, 2010 | 9.54% |